Patient Guide: A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 268 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07076121
Status: 🟢 Enrolling Now
Condition: Pancreatic Ductal Adenocarcinoma
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 268 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Springdale, Arkansas
  • • La Jolla, California
  • • And 265 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) - Join Clinical Trial NCTNCT07076121

How to Join This Clinical Trial - NCTNCT07076121

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Pancreatic Ductal Adenocarcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Pancreatic Ductal Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Pancreatic Ductal Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07076121 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 268 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Francisco, California 94115 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: WITHDRAWN

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: RECRUITING

Clinical Research Site

Boise, Idaho 83712 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Westwood, Kansas 66205 - United States

Status: NOT_YET_RECRUITING

And 258 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Pancreatic Ductal Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships